Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 4, 2009 - Issue 5
Submit an article Journal homepage
36
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Animal studies trigger new insights on the use of methadone maintenance

Erin Cummins PhD Student University of Guelph, Department of Psychology, Guelph (ON), N1G 2W1, Canada
, MA &
Francesco Leri Associate Professor University of Guelph, Department of Psychology, Guelph (ON), N1G 2W1, Canada +1 519 824 4120, Ext 58264; +1 519 837 8629; [email protected]
, PhD
Pages 577-586 | Published online: 07 May 2009

Bibliography

  • Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, editors, Gilman, Goodman. The pharmacological basis of therapeutics. New York, McGraw-Hill 2001. p. 569-619
  • Kristensen K, Christensen CB, Christrup LL. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 1995;56:L45-50
  • Ebert B, Thorkildsen C, Andersen S, et al. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists. Biochem Pharmacol 1998;56:553-9
  • Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett 1995;187:165-8
  • Horng JS, Smits SE, Wong DT. The binding of the optical isomers of methadone, alpha-methadol, alpha-acetylmethadol and their N-demethylated derivatives to the opiate receptors of rat brain. Res Commun Chem Pathol Pharmacol 1976;14:621-9
  • Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther 1999;289:1048-53
  • Ingoglia NA, Dole VP. Localization of d- and l-methadone after intraventricular injection into rat brains. J Pharmacol Exp Ther 1970;175:84-7
  • Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002;18(Suppl. 4):S3-13
  • Choi DW, Viseskul V. Opioids and non-opioid enantiomers selectively attenuate N-methyl-D-aspartate neurotoxicity on cortical neurons. Eur J Pharmacol 1988;155:27-35
  • Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett 1997;223:5-8
  • Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 2005;19:13-24
  • Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 2000;909:186-216
  • Layson-Wolf C, Goode JV, Small RE. Clinical use of methadone. J Pain Palliat Care Pharmacother 2002;16:29-59
  • Inturrisi CE, Colburn WA, Kaiko RF, et al. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 1987;41:392-401
  • Paalzow LK. Pharmacokinetic aspects of optimal pain treatment. Acta Anaesthesiol Scand Suppl 1982;74:37-43
  • Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 2002;41:1153-93
  • Nilsson MI, Meresaar U, Anggard E. Clinical pharmacokinetics of methadone. Acta Anaesthesiol Scand Suppl 1982;74:66-9
  • Cohn GL, Cramer JA, McBride W, et al. Heroin and morphine binding with human serum proteins and red blood cells. Proc Soc Exp Biol Med 1974;147:664-6
  • Olsen GD. Methadone binding to human plasma albumin. Science 1972;176:525-6
  • Olsen GD. Methadone binding to human plasma proteins. Clin Pharmacol Ther 1973;14:338-43
  • Romach MK, Piafsky KM, Abel JG, et al. Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther 1981;29:211-7
  • Abramson FP. Methadone plasma protein binding: alterations in cancer and displacement from alpha 1-acid glycoprotein. Clin Pharmacol Ther 1982;32:652-8
  • de Vos JW, Geerlings PJ, van den BW, et al. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. Eur J Clin Pharmacol 1995;48:361-6
  • Zhou Y, Spangler R, Maggos CE, et al. Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin. Eur J Pharmacol 1996;315:31-5
  • Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA 1965;193:646-50
  • Barnett PG, Hui SS. The cost-effectiveness of methadone maintenance. Mt Sinai J Med 2000;67:365-74
  • Maxwell S, Shinderman M. Optimizing response to methadone maintenance treatment: use of higher-dose methadone. J Psychoactive Drugs 1999;31:95-102
  • Kleber HD. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA 2008;300:2303-5
  • Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 2000;909:186-216
  • Kreek MJ. Rationale for maintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res Nerv Ment Dis 1992;70:205-30
  • Schluger JH, Borg L, Ho A, et al. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Neuropsychopharmacology 2001;24:568-75
  • Condelli WS, Dunteman GH. Exposure to methadone programs and heroin use. Am J Drug Alcohol Abuse 1993;19:65-78
  • Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med 1966;118:304-9
  • Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep 1998;113(Suppl 1):107-15
  • Caplehorn JR, Ross MW. Methadone maintenance and the likelihood of risky needle-sharing. Int J Addict 1995;30:685-98
  • Gossop M, Marsden J, Stewart D, et al. Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study. AIDS Care 2002;14:77-93
  • Lollis CM, Strothers HS, Chitwood DD, et al. Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior? J Behav Med 2000;23:545-57
  • Dole VP, Nyswander ME, Warner AA. Successful treatment of 750 criminal addicts. JAMA 1968;206:2708-11
  • Schwartz RP, Kelly SM, O'Grady KE, et al. In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history. Am J Drug Alcohol Abuse 2008;34:17-28
  • Rounsaville BJ, Kosten TR, Kleber HD. The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study. Am J Drug Alcohol Abuse 1987;13:213-29
  • Leri F, Stewart J, Fischer B, et al. Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals. Exp Clin Psychopharmacol 2005;13:303-10
  • Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003;98:7-22
  • Dobler-Mikola A, Hattenschwiler J, Meili D, et al. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J Subst Abuse Treat 2005;29:259-65
  • Kolar AF, Brown BS, Weddington WW, et al. A treatment crisis: cocaine use by clients in methadone maintenance programs. NIDA Res Monogr 1990;105:365-6
  • Condelli WS, Fairbank JA, Dennis ML, et al. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J Subst Abuse Treat 1991;8:203-12
  • Levin FR, Foltin RW, Fischman MW. Pattern of cocaine use in methadone-maintained individuals applying for research studies. J Addict Dis 1996;15:97-106
  • Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviors. Drug Alcohol Depend 1995;37:7-14
  • Bux DA, Lamb RJ, Iguchi MY. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend 1995;37:29-35
  • Chaisson RE, Bacchetti P, Osmond D, et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989;261:561-5
  • Callaghan RC, Cunningham JA. Intravenous and non-intravenous cocaine abusers admitted to inpatient detoxification treatment: a 3-year medical-chart review of patient characteristics and predictors of treatment re-admission. Drug Alcohol Depend 2002;68:323-8
  • Hunt DE, Lipton DS, Goldsmith D, et al. Street pharmacology: uses of cocaine and heroin in the treatment of addiction. Drug Alcohol Depend 1984;13:375-87
  • Grella CE, Anglin MD, Wugalter SE. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Am J Drug Alcohol Abuse 1997;23:15-42
  • Strug DL, Hunt DE, Goldsmith DS, et al. Patterns of cocaine use among methadone clients. Int J Addict 1985;20:1163-75
  • Joe GW, Simpson DD. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend 1995;37:23-8
  • Hartel DM, Schoenbaum EE, Selwyn PA, et al. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health 1995;85:83-8
  • Downey KK, Helmus TC, Schuster CR. Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance. Exp Clin Psychopharmacol 2000;8:176-84
  • Maddux JF, Prihoda TJ, Vogtsberger KN. The relationship of methadone dose and other variables to outcomes of methadone maintenance. Am J Addict 1997;6:246-55
  • Black JL, Dolan MP, Penk WE, et al. The effect of increased cocaine use on drug treatment. Addict Behav 1987;12:289-92
  • Kerr T, Marsh D, Li K, et al. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005;80:329-35
  • Magura S, Nwakeze PC, Demsky SY. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998;93:51-60
  • Magura S, Siddiqi Q, Freeman RC, et al. Changes in cocaine use after entry to methadone treatment. J Addict Dis 1991;10:31-45
  • Shaffer HJ, Lasalvia TA. Patterns of substance use among methadone maintenance patients. Indicators of outcome. J Subst Abuse Treat 1992;9:143-7
  • Faggiano F, Vigna-Taglianti F, Versino E, et al. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003;63:CD002208
  • Strain EC, Stitzer ML, Liebson IA, et al. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 1993;119:23-7
  • Stine SM, Burns B, Kosten T. Methadone dose for cocaine abuse. Am J Psychiatry 1991;148:1268
  • Schottenfeld RS, Chawarski MC, Pakes JR, et al. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry 2005;162:340-9
  • Peles E, Kreek MJ, Kellogg S, et al. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis 2006;25:43-50
  • Foltin RW, Fischman MW. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther 1996;278:1153-64
  • Preston KL, Sullivan JT, Strain EC, et al. Enhancement of cocaine's abuse liability in methadone maintenance patients. Psychopharmacology (Berl) 1996;123:15-25
  • Foltin RW, Christiansen I, Levin FR, et al. Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J Pharmacol Exp Ther 1995;275:38-47
  • Panlilio LV, Goldberg SR. Self-administration of drugs in animals and humans as a model and an investigative tool. Addiction 2007;102:1863-70
  • Mueller D, Stewart J. Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 2000;115:39-47
  • Markou A, Weiss F, Gold LH, et al. Animal models of drug craving. Psychopharmacology (Berl) 1993;112:163-82
  • Shaham Y, Shalev U, Lu L, et al. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 2003;168:3-20
  • Mueller D, Perdikaris D, Stewart J. Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res 2002;136:389-97
  • Bilsky EJ, Montegut MJ, Delong CL, et al. Opioidergic modulation of cocaine conditioned place preferences. Life Sci 1992;50:L85-90
  • Wang NS, Brown VL, Grabowski J, et al. Reinforcement by orally delivered methadone, cocaine, and methadone-cocaine combinations in rhesus monkeys: are the combinations better reinforcers? Psychopharmacology (Berl) 2001;156:63-72
  • Leri F, Sorge RE, Cummins E, et al. High-dose methadone maintenance in rats: effects on cocaine self-administration and behavioral side effects. Neuropsychopharmacology 2007;32:2290-300
  • Leri F, Zhou Y, Goddard B, et al. Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain. Neuropsychopharmacology 2006;31:1462-74
  • Leri F, Zhou Y, Goddard B, et al. Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain. Eur Neuropsychopharmacol 2009;19:238-49
  • Leri F, Tremblay A, Sorge RE, et al. Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology 2004;29:1312-20
  • Leri F, Stewart J. Drug-induced reinstatement to heroin and cocaine seeking: a rodent model of relapse in polydrug use. Exp Clin Psychopharmacol 2001;9:297-306
  • Shaham Y, Shalev U, Lu L, et al. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 2003;168:3-20
  • Di CG, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988;85:5274-8
  • Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997;9:482-97
  • Hemby SE, Co C, Dworkin SI, et al. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats. J Pharmacol Exp Ther 1999;288:274-80
  • Zernig G, O'Laughlin IA, Fibiger HC. Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens. Eur J Pharmacol 1997;337:1-10
  • Stafford D, LeSage MG, Glowa JR. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology (Berl) 1998;139:169-84
  • Negus SS, Mello NK. Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend 2004;74:297-309
  • Calcagnetti DJ, Schechter MD. Extinction of cocaine-induced place approach in rats: a validation of the “biased” conditioning procedure. Brain Res Bull 1993;30:695-700
  • Goddard B, Leri F. Reinstatement of conditioned reinforcing properties of cocaine-conditioned stimuli. Pharmacol Biochem Behav 2006;83:540-6
  • Leri F, Sorge RE, Cummins E, et al. High-dose methadone maintenance in rats: effects on cocaine self-administration and behavioral side effects. Neuropsychopharmacology 2007;32:2290-300
  • Daniell HW. Narcotic-induced hypogonadism during therapy for heroin addiction. J Addict Dis 2002;21:47-53
  • Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002;3:377-84
  • Fischer B, Chin AT, Kuo I, et al. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse 2002;37:495-522
  • Mirin SM, Meyer RE, Mendelson JH, et al. Opiate use and sexual function. Am J Psychiatry 1980;137:909-15
  • Negus SS. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 2006;317:711-23
  • Negus SS, Mello NK. Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend 2004;74:297-309
  • Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain 2001;90:91-6
  • Pud D, Cohen D, Lawental E, et al. Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 2006;82:218-23
  • Mendelson SD, Pfaus JG. Level searching: a new assay of sexual motivation in the male rat. Physiol Behav 1989;45:337-41
  • Pfaus JG, Mendelson SD, Phillips AG. A correlational and factor analysis of anticipatory and consummatory measures of sexual behavior in the male rat. Psychoneuroendocrinology 1990;15:329-40
  • Everitt BJ, Wolf ME. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 2002;22:3312-20
  • Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005;162:1403-13
  • Kreek MJ. Drug addictions. Molecular and cellular endpoints. Ann NY Acad Sci 2001;937:27-49
  • Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001;2:119-28
  • Nestler EJ. Neurobiology. Total recall-the memory of addiction. Science 2001;292:2266-7
  • Roth-Deri I, Zangen A, Aleli M, et al. Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens. J Neurochem 2003;84:930-8
  • Spangler R, Unterwald EM, Kreek MJ. ‘Binge’ cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res 1993;19:323-7
  • Ziolkowska B, Stefanski R, Mierzejewski P, et al. Contingency does not contribute to the effects of cocaine self-administration on prodynorphin and proenkephalin gene expression in the rat forebrain. Brain Res 2006;1069:1-9
  • Bailey A, Yuferov V, Bendor J, et al. Immediate withdrawal from chronic “binge” cocaine administration increases mu-opioid receptor mRNA levels in rat frontal cortex. Brain Res Mol Brain Res 2005;137:258-62
  • Turchan J, Maj M, Przewlocka B, et al. Effect of cocaine and amphetamine on biosynthesis of proenkephalin and prodynorphin in some regions of the rat limbic system. Pol J Pharmacol 2002;54:367-72
  • Turchan J, Przewlocka B, Lason W, et al. Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience 1998;85:1051-9
  • Cohen BM, Nguyen TV, Hyman SE. Cocaine-induced changes in gene expression in rat brain. NIDA Res Monogr 1990;105:175-81
  • Hurd YL, Brown EE, Finlay JM, et al. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res Mol Brain Res 1992;13:165-70
  • Hurd YL, Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 1993;13:357-69
  • Sivam SP. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 1989;250:818-24
  • Unterwald EM, Rubenfeld JM, Kreek MJ. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 1994;5:1613-6
  • Unterwald EM. Regulation of opioid receptors by cocaine. Ann NY Acad Sci 2001;937:74-92
  • Izenwasser S, Heller B, Cox BM. Continuous cocaine administration enhances mu- but not delta-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens. Eur J Pharmacol 1996;297:187-91
  • Yuferov V, Zhou Y, Spangler R, et al. Acute “binge” cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system. Brain Res Bull 1999;48:109-12
  • Azaryan AV, Clock BJ, Cox BM. Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation. Neurochem Res 1996;21:1411-5
  • Azaryan AV, Clock BJ, Rosenberger JG, et al. Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol 1998;76:278-83
  • Collins SL, Kunko PM, Ladenheim B, et al. Chronic cocaine increases kappa-opioid receptor density: lack of effect by selective dopamine uptake inhibitors. Synapse 2002;45:153-8
  • Unterwald EM, Kreek MJ, Cuntapay M. The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res 2001;900:103-9
  • Hurd YL, Svensson P, Ponten M. The role of dopamine, dynorphin, and CART systems in the ventral striatum and amygdala in cocaine abuse. Ann NY Acad Sci 1999;877:499-506
  • Staley JK, Rothman RB, Rice KC, et al. Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. J Neurosci 1997;17:8225-33
  • Wise RA. The role of reward pathways in the development of drug dependence. Pharmacol Ther 1987;35:227-63
  • Di CG. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995;38:95-137
  • Zubieta JK, Gorelick DA, Stauffer R, et al. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 1996;2:1225-9
  • Gorelick DA, Kim YK, Bencherif B, et al. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 2005;57:1573-82
  • Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-85
  • de LL, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998;95:322-7
  • Georgescu D, Zachariou V, Barrot M, et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003;23:3106-11
  • Narita M, Nagumo Y, Hashimoto S, et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006;26:398-405
  • Boutrel B, Kenny PJ, Specio SE, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA 2005;102:19168-73
  • De Vries TJ, Schoffelmeer AN, Binnekade R, et al. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 2002;26:18-26
  • Nader MA, Czoty PW. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am J Psychiatry 2005;162:1473-82
  • Dalley JW, Fryer TD, Brichard L, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007;315:1267-70
  • Ambrose LM, Unterwald EM, Van Bockstaele EJ. Ultrastructural evidence for co-localization of dopamine D2 and micro-opioid receptors in the rat dorsolateral striatum. Anat Rec A Discov Mol Cell Evol Biol 2004;279:583-91
  • Volkow ND, Wang GJ, Telang F, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006;26:6583-8
  • Volkow ND, Fowler JS, Wang GJ, et al. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 2007;64:1575-9
  • Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci 2007;8:844-58
  • Nugent FS, Penick EC, Kauer JA. Opioids block long-term potentiation of inhibitory synapses. Nature 2007;446:1086-90
  • Rowan-Szal GA, Bartholomew NG, Chatham LR, et al. A combined cognitive and behavioral intervention for cocaine-using methadone clients. J Psychoactive Drugs 2005;37:75-84
  • Connock M, Juarez-Garcia A, Jowett S, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 2007;11:1-171
  • Schottenfeld RS, Pakes J, Ziedonis D, et al. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry 1993;34:66-74
  • Mello NK, Negus SS. The effects of buprenorphine on self-administration of cocaine and heroin “speedball” combinations and heroin alone by rhesus monkeys. J Pharmacol Exp Ther 1998;285:444-56
  • Lukas SE, Mello NK, Drieze JM, Mendelson JH. Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis. Drug Alcohol Depend 1995;40:87-98
  • Sorge RE, Stewart J. The effects of chronic buprenorphine on intake of heroin and cocaine in rats and its effects on nucleus accumbens dopamine levels during self-administration. Psychopharmacology (Berl) 2006;188:28-41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.